Bibliography
- FOSSA AA, WISIALOWSKI T, MAGNANO A et al.: Dynamic beat-to-beat modeling of the QT-RR interval relationship: analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition. J. Pharmacol. Exp. Ther. (2005) 312 (1):1-11.
- FOSSA AA, WISIALOWSKI T, CRIMIN K: QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ-interval relationship during normal sinus rhythm under varying states of repolarization. J. Pharmacol. Exp. Ther. (2006) 316(2):498-506.
- CAVERO I, CRUMB W: Safety Pharmacology Society: 5th Annual Meeting. 27-29 September 2005, Mannheim, Germany. Expert Opin. Drug Saf. (2006) 5(1):181-185
- CAVERO I, CRUMB W: ICH S7B guideline on the clinical strategy for testing delayed cardiac repolarization risk of drugs: a critical analysis. Expert Opin. Drug Saf. (2005) 4(3):509-530.
- CAVERO I, CRUMB W: ICH The use of electrocardiograms in clinical trials: a public discussion of the proposed ICH E14 regulatory guidance. April 11-12, 2005, Bethesda, MD, USA. Expert Opin. Drug Saf. (2005) 4(4):795-799.
Websites
- http://www.hesiglobal.org/Events/TdPWorkshop.htm ILSI Health and Environmental Sciences Institute (HESI) website (2006).
- http://www.ich.org/LOB/media/MEDIA2192.pdf ICH harmonised tripartite guideline. The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. S7B (2005).